Home › Funds › Logos Global Management LP › IMCR
Logos Global Management LP position in IMCR
IMMUNOCORE HLDGS PLC · Health Care
Logos Global Management LP reported holding 600,000 shares of IMCR (IMMUNOCORE HLDGS PLC) in its Q2 2026 13F filing — a position valued at US$19.1M, representing 0.82% of its reported portfolio and ranking #37 among its reported holdings. Logos Global Management LP has disclosed IMCR holdings in 8 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Logos Global Management LP's IMCR position evolved
Logos Global Management LP first disclosed a stake in IMCR in Q3 2023 at 450,000 shares (US$23.4M). The position peaked in Q1 2024 at 900,000 shares, worth US$58.5M. Across 8 filings, Logos Global Management LP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 600,000 shares valued at US$19.1M — a reduction of -900,000 shares quarter over quarter.. Notable position changes include a 125% increase in Q1 2024 (shares fell 48% over the following quarter), a 76% increase in Q1 2026 (shares rose 5% over the following quarter), a 60% trim in Q2 2026 (shares fell 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 450.00K | $23.36M | New |
| Q4 2023 | 400.00K | $27.33M | Reduce |
| Q1 2024 | 900.00K | $58.50M | Add |
| Q2 2025 | 575.00K | $18.04M | New |
| Q3 2025 | 850.00K | $30.88M | Add |
| Q4 2025 | 850.00K | $29.50M | Hold |
| Q1 2026 | 1.50M | $45.23M | Add |
| Q2 2026 | 600.00K | $19.05M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMCR and 13F data
IMCR (IMMUNOCORE HLDGS PLC) is a Health Care company. 31 other funds we track also report a position in IMCR — the largest reported positions include RTW INVESTMENTS, LP (US$154.6M), Bellevue Group AG (US$88.5M), TANG CAPITAL MANAGEMENT LLC (US$84.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMCR
- RTW INVESTMENTS, LP 4.87M sh · $154.62M · Q2 2026
- Bellevue Group AG 2.79M sh · $88.53M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 2.65M sh · $84.12M · Q2 2026
- Vestal Point Capital, LP 1.80M sh · $57.15M · Q2 2026
- ARMISTICE CAPITAL, LLC 1.43M sh · $45.34M · Q2 2026
- Caligan Partners LP 1.38M sh · $43.86M · Q2 2026
- Kynam Capital Management, LP 1.38M sh · $43.66M · Q2 2026
- BVF INC/IL 1.29M sh · $41.10M · Q2 2026
- Trails Edge Capital Partners, LP 1.06M sh · $33.76M · Q2 2026
- Jones Hill Capital LP 512.86K sh · $16.28M · Q2 2026
- Frazier Life Sciences Management, L.P. 484.78K sh · $15.39M · Q2 2026
- Fulcrum Asset Management LLP 470.02K sh · $14.30M · Q2 2026
More on Logos Global Management LP
FAQ
How long has Logos Global Management LP held IMCR?
Logos Global Management LP has disclosed IMCR holdings in 8 of the last 12 reported quarters, going back to Q3 2023.
What is Logos Global Management LP's current position in IMCR?
As of Q2 2026, Logos Global Management LP holds 600.00K shares of IMCR (IMMUNOCORE HLDGS PLC), valued at $19.05M, representing 0.82% of its reported portfolio and ranking #37.
Has Logos Global Management LP been buying or selling IMCR?
In the latest 13F filing (Q2 2026), Logos Global Management LP reduced its position in IMCR. The position peaked in Q1 2024 at 900.00K shares.
Which other funds hold IMCR?
Other major institutional holders of IMCR include RTW INVESTMENTS, LP, Bellevue Group AG, TANG CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.